# FDA Inspection 1319534 - Biomat USA Inc - May 27, 2026

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/be65bb78-1b7a-4c2b-98b1-e17c64061680
Source feed: FDA_Inspections

> FDA Inspection 1319534 for Biomat USA Inc on May 27, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1319534
- Company Name: Biomat USA Inc
- Inspection Date: 2026-05-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1325870 - 2026-06-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/10595f05-9606-4462-a0fd-ae8e93421a36)
- [FDA Inspection 1315894 - 2026-04-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/bf399e7a-8494-49f5-8ef5-3f5e4aa7bfae)
- [FDA Inspection 1316814 - 2026-04-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/de771764-6af2-4260-8be8-1d8b29877590)
- [FDA Inspection 1284418 - 2026-04-02](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/74f3a74f-0489-4fc2-af02-39d40a466c6f)
- [FDA Inspection 1306756 - 2026-03-05](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/58074812-4fde-4319-9fe8-cd34eae9a713)

Company: https://www.keypedia.com/companies/biomat-usa-inc/3aeaac2d-a7fb-46ea-9b63-c05a6090e244

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d